Wellgistics Health to Report Third Quarter 2025 Financial Results and Provide a Business Update on the morning of Thursday, November 20th, 2025
Rhea-AI Summary
Wellgistics Health (NASDAQ:WGRX) will report third quarter 2025 financial results and provide a business update on the morning of Thursday, November 20, 2025.
The results will cover the period ended September 30, 2025. The company operates in health information technology for prescription drug distribution from manufacturer to patient through licensed pharmacies.
Positive
- None.
Negative
- None.
News Market Reaction – WGRX
On the day this news was published, WGRX declined 9.36%, reflecting a notable negative market reaction. Argus tracked a peak move of +4.6% during that session. Argus tracked a trough of -14.6% from its starting point during tracking. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $7M from the company's valuation, bringing the market cap to $64M at that time.
Data tracked by StockTitan Argus on the day of publication.
TAMPA, FL / ACCESS Newswire / November 17, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader at the nexus of the physical and technology healthcare infrastructures for prescription drug distribution from manufacturer to patient through licensed pharmacies, today announced that it will report third quarter 2025 provide a business update and report financial results for the period ended September 30, 2025 on the morning of Thursday, November 20, 2025.
About Wellgistics Health, Inc.
Wellgistics Health (NASDAQ:WGRX) is pharmacy physical and technology enabling health IT company that specializes in optimizing the delivery medications from manufacturers to patients. Its integrated platform connects 6,500+ pharmacies and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. Wellgistics provides end-to-end solutions designed to restore access, transparency, and trust in U.S. healthcare.
For more information, visit www.wellgisticshealth.com.
Forward-Looking Statements
This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate," or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially. Additional factors are discussed in Wellgistics Health's filings with the SEC, available at www.sec.gov.
Media & Investor Contact
Media:
media@wellgisticshealth.com
Investor Relations:
IR@wellgisticshealth.com
Investor Relations Contact
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, NY 10036
Office: (646) 893-5835
Email: info@skylineccg.com
SOURCE: Wellgistics Health, Inc.
View the original press release on ACCESS Newswire
FAQ
When will Wellgistics Health (WGRX) release Q3 2025 financial results?
What period do Wellgistics Health's Q3 2025 results cover for WGRX?
Will Wellgistics (WGRX) provide a business update with the Q3 2025 results?
What business does Wellgistics Health (WGRX) operate in?
Does the announcement state how investors can access the WGRX Q3 2025 report or presentation?
Who is the issuer of the November 17, 2025 notice about WGRX results?
